HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph A Jakubowski Selected Research

Purinergic P2Y Receptor Antagonists

1/2018Population Pharmacokinetic and Exposure-Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia.
4/2017The Rationale for and Clinical Pharmacology of Prasugrel 5 mg.
4/2016Prasugrel, a Platelet P2Y12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia.
9/2014Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
2/2014A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation.
6/2010Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph A Jakubowski Research Topics

Disease

20Coronary Artery Disease (Coronary Atherosclerosis)
09/2014 - 05/2006
17Acute Coronary Syndrome
10/2020 - 01/2007
17Hemorrhage
11/2016 - 06/2006
13Thrombosis (Thrombus)
04/2016 - 12/2002
11Sickle Cell Anemia (Hemoglobin S Disease)
01/2018 - 02/2013
10Myocardial Infarction
07/2017 - 12/2007
4Body Weight (Weight, Body)
09/2014 - 03/2011
4Hyperglycemia
04/2006 - 10/2004
3Pain (Aches)
12/2017 - 02/2013
3Cerebral Infarction
10/2016 - 06/2009
3Infarction (Infarctions)
10/2016 - 06/2009
3Diabetes Mellitus
04/2015 - 04/2011
3Sepsis (Septicemia)
01/2008 - 07/2004
2Hemolysis
12/2017 - 01/2014
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2016 - 12/2015
2Ischemic Stroke
10/2016 - 12/2015
2Ischemia
04/2016 - 01/2014
2Stroke (Strokes)
03/2016 - 09/2013
2Cardiovascular Diseases (Cardiovascular Disease)
04/2015 - 01/2007
2Type 2 Diabetes Mellitus (MODY)
09/2014 - 04/2011
2Arterial Occlusive Diseases (Arterial Occlusive Disease)
06/2009 - 01/2008
2Critical Illness (Critically Ill)
04/2006 - 10/2004
2Bacteremia
10/2004 - 07/2004
1Acute Chest Syndrome
11/2019
1Neurologic Manifestations (Neurological Manifestations)
10/2016
1Intracranial Thrombosis (Cerebral Thrombosis)
10/2016
1Thalassemia
02/2016
1Hyperplasia
12/2015
1Carotid Artery Injuries
12/2015
1Fibrosis (Cirrhosis)
12/2015
1Thrombotic Stroke
12/2015
1Obesity
10/2014
1ST Elevation Myocardial Infarction
11/2012
1Unstable Angina
11/2012
1Platelet Storage Pool Deficiency
11/2012
1Neoplasms (Cancer)
07/2012
1Coronary Disease (Coronary Heart Disease)
06/2012
1Death (Near-Death Experience)
06/2012
1Necrosis
09/2011
1Cardiac Arrhythmias (Arrythmia)
09/2011
1Rupture
12/2010
1Carotid Stenosis (Carotid Artery Stenosis)
12/2010

Drug/Important Bio-Agent (IBA)

53Prasugrel HydrochlorideFDA Link
01/2018 - 04/2005
35Clopidogrel (Plavix)FDA Link
03/2016 - 05/2006
13Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2017 - 04/2005
11Adenosine Diphosphate (ADP)IBA
01/2018 - 07/2009
7thienopyridineIBA
04/2017 - 12/2007
6Purinergic P2Y Receptor AntagonistsIBA
01/2018 - 06/2010
5Biomarkers (Surrogate Marker)IBA
07/2017 - 07/2004
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
02/2016 - 02/2010
4Protein CIBA
01/2008 - 07/2004
3Pharmaceutical PreparationsIBA
12/2017 - 04/2007
3Cytochrome P-450 CYP2C19IBA
03/2016 - 12/2013
3Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2016 - 04/2005
3ChemokinesIBA
01/2008 - 07/2004
3Insulin (Novolin)FDA Link
04/2006 - 10/2004
3Blood Glucose (Blood Sugar)IBA
11/2005 - 07/2004
2Hemoglobins (Hemoglobin)IBA
12/2017 - 02/2016
2Adenosine (Adenocard)FDA LinkGeneric
12/2017 - 01/2014
2R-138727IBA
10/2016 - 05/2013
2ferric chlorideIBA
04/2016 - 12/2015
2Messenger RNA (mRNA)IBA
12/2015 - 03/2006
2SolutionsIBA
12/2015 - 03/2006
2Ticlopidine (Ticlid)FDA LinkGeneric
01/2008 - 01/2007
2Blood Proteins (Serum Proteins)IBA
12/2007 - 07/2004
2Xylazine (Xylazin)IBA
03/2006 - 11/2005
2KetamineFDA LinkGeneric
03/2006 - 11/2005
2Glucose (Dextrose)FDA LinkGeneric
03/2006 - 11/2005
1MicroRNAs (MicroRNA)IBA
10/2020
1Hydroxyurea (Hydrea)FDA LinkGeneric
11/2019
1Analgesics (Analgesic Drugs)IBA
12/2017
1pro-brain natriuretic peptide (1-76)IBA
07/2017
1C-Reactive ProteinIBA
07/2017
1antineoplaston A10 (A 10)IBA
07/2017
1P-SelectinIBA
10/2016
1Sickle HemoglobinIBA
02/2016
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2015
1Fibrinogen (Factor I)FDA Link
04/2015
1Proton Pump InhibitorsIBA
10/2014
1N 30IBA
09/2014
1ThienopyridinesIBA
09/2014
1TicagrelorIBA
04/2014
1A-factor (Streptomyces)IBA
09/2013
1TroponinIBA
09/2013
1Glycoproteins (Glycoprotein)IBA
09/2013
1Abciximab (ReoPro)FDA Link
05/2013
1ProdrugsIBA
09/2011
1Purinergic P1 Receptors (Adenosine Receptor)IBA
09/2011
1Warfarin (Coumadin)FDA LinkGeneric
12/2010
1Thromboplastin (Tissue Factor)IBA
12/2010
1ThrombinFDA Link
12/2010

Therapy/Procedure

12Percutaneous Coronary Intervention
04/2017 - 01/2007
11Therapeutics
11/2016 - 04/2006
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2016 - 06/2012
3Punctures
04/2006 - 07/2004
3Ligation
04/2006 - 07/2004
2Oral Administration
06/2009 - 01/2008
2Anesthesia
03/2006 - 11/2005
1Stents
07/2012
1Drug-Eluting Stents
06/2012